Acquired resistance mechanisms to afatinib in HER2‐amplified gastric cancer cells

Cancer treatment, especially that for breast and lung cancer, has entered a new era and continues to evolve, with the development of genome analysis technology and the advent of molecular targeted drugs including tyrosine kinase inhibitors. Nevertheless, acquired drug resistance to molecular targete...

Full description

Saved in:
Bibliographic Details
Published in:Cancer Sci
Main Authors: Yoshioka, Takahiro, Shien, Kazuhiko, Takeda, Tatsuaki, Takahashi, Yuta, Kurihara, Eisuke, Ogoshi, Yusuke, Namba, Kei, Torigoe, Hidejiro, Sato, Hiroki, Tomida, Shuta, Yamamoto, Hiromasa, Soh, Junichi, Fujiwara, Toshiyoshi, Toyooka, Shinichi
Format: Artigo
Language:Inglês
Published: John Wiley and Sons Inc. 2019
Subjects:
Original Articles
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6676122/
https://ncbi.nlm.nih.gov/pubmed/31162771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.14089
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items